Index  ›  health  ›  Medical News Today

Ozempic and autoimmune disease: Safety questions answered

Medical News Today Published Mar 25, 2026 Reviewed Jul 3, 2026 ✓ Reviewed by citations.press editors
Citation-ready fact
Ozempic (semaglutide) is approved for adults with type 2 diabetes to help manage blood sugar, lower the risk of heart attack and stroke in those with heart disease, and reduce the risk of kidney failure and worsening kidney disease in those with chronic kidney disease.
View source ↗
Citation-ready fact
Rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) are the two autoimmune conditions where researchers see the most potential for GLP-1 drugs.
View source ↗
Citation-ready fact
GLP-1 medications reduce inflammation by lowering certain blood markers such as C-reactive protein (CRP).
View source ↗
Citation-ready fact
Early research suggests Ozempic may help calm an overactive immune system.
View source ↗
Citation-ready fact
There have been rare reports of drug-induced lupus and other immune-related side effects in a small number of people taking Ozempic.
View source ↗
Citation-ready fact
Some people who started Ozempic developed drug-induced lupus, where semaglutide triggered the immune system to attack healthy tissues.
View source ↗
Citation-ready fact
One study found that patients with RA who took semaglutide had better joint health over time.
View source ↗
Citation-ready fact
Symptoms like new joint pain, skin rashes (especially after sun exposure), or extreme fatigue may occur after starting Ozempic and usually resolve after discontinuation.
View source ↗

Ozempic (semaglutide) is a GLP-1 receptor agonist approved for adults with type 2 diabetes to help manage blood sugar, to lower the risk of heart attack and stroke in those with heart disease, and to reduce the risk of kidney failure and worsening kidney disease in those with chronic kidney disease.

Researchers are now exploring whether GLP-1 medications may affect inflammation and immune function, with early studies showing potential benefits for certain autoimmune conditions. These findings are emerging and not yet part of standard care.

Not currently. However, scientists are very interested in the drug’s potential for this use. Early research suggests that the way Ozempic works in the body might also help calm down an overactive immune system. While these early signs are exciting, we don’t have enough proof yet. Doctors still need to run large clinical trials to see if Ozempic is truly effective and safe for treating autoimmune flares before it can be used that way.

For many people, the answer is yes. If you have an autoimmune disease and also need help managing type 2 diabetes, Ozempic might be a helpful tool. Many patients with conditions such as arthritis have used GLP-1 medications without issues.

That said, everyone’s body is different. There have been rare reports of drug-induced lupus and other immune-related side effects in a small number of people. Because autoimmune diseases are complex, you should always talk with your healthcare team (especially your rheumatologist) before starting a new medication to make sure it won’t interfere with your current treatments.

Currently, rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) are the two areas where researchers see the most potential. Recent data from major medical conferences shows that GLP-1 drugs might help people with rheumatic diseases feel better. For example, one study found that patients with RA who took semaglutide actually had better joint health over time.

For people with IBD — like Crohn’s disease or ulcerative colitis (UC) — research suggests the drug may help by reducing swelling in the gut and helping the lining of the intestines heal. Researchers are also starting to look at other conditions like psoriasis and multiple sclerosis, but that work is still in the very early stages.

GLP-1 medications like Ozempic can help lower inflammation throughout the body. They do this by reducing certain “markers” in the blood, such as C-reactive protein (CRP), that show the body is under stress or fighting something.

While the medication might interact directly with immune cells to help them behave normally, most of these changes happen indirectly. This means the lower inflammation is mostly driven by the fact that patients are losing weight and their metabolism is getting healthier. Since body fat itself can create inflammatory signals, losing that fat helps the whole system calm down. Scientists are still studying the exact ways this happens.

Although it’s rare, some people have developed new immune problems after starting Ozempic. Specifically, there have been cases where semaglutide was linked to a condition called drug-induced lupus. This is when a medication triggers the immune system to mistakenly attack the body’s own healthy tissues.

If you start Ozempic, you should keep an eye out for new symptoms, like new joint pain, skin rashes (especially after being in the sun), or feeling extremely tired for no reason. The good news is that for most people, these symptoms usually go away once they stop taking the medication.

Disclaimer: While Medical News Today strives for factual, comprehensive, and current information, this article is not a substitute for a licensed healthcare professional’s expertise. Always consult a doctor before taking or discontinuing any medication. Drug information is subject to change and may not cover all uses, directions, precautions, warnings, interactions, reactions, or adverse effects. The lack of a warning does not guarantee a drug’s safety, effectiveness, or appropriateness for all patients or specific uses. Learn more about our approach to content integrity.

This article was originally published by Medical News Today ↗. citations.press indexes the source-backed facts above and links to the original. Something wrong? Corrections policy · Report an error